GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Usana Health Sciences Inc (STU:USJ) » Definitions » EV-to-Revenue

Usana Health Sciences (STU:USJ) EV-to-Revenue : 0.51 (As of Jul. 16, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Usana Health Sciences EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Usana Health Sciences's enterprise value is €412.1 Mil. Usana Health Sciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was €813.0 Mil. Therefore, Usana Health Sciences's EV-to-Revenue for today is 0.51.

The historical rank and industry rank for Usana Health Sciences's EV-to-Revenue or its related term are showing as below:

STU:USJ' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.32   Med: 1.32   Max: 2.66
Current: 0.55

During the past 13 years, the highest EV-to-Revenue of Usana Health Sciences was 2.66. The lowest was 0.32. And the median was 1.32.

STU:USJ's EV-to-Revenue is ranked better than
78.52% of 1899 companies
in the Consumer Packaged Goods industry
Industry Median: 1.18 vs STU:USJ: 0.55

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-07-16), Usana Health Sciences's stock price is €26.60. Usana Health Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was €42.55. Therefore, Usana Health Sciences's PS Ratio for today is 0.63.


Usana Health Sciences EV-to-Revenue Historical Data

The historical data trend for Usana Health Sciences's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Usana Health Sciences EV-to-Revenue Chart

Usana Health Sciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.16 1.46 0.74 0.76 0.69

Usana Health Sciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.66 0.60 0.41 0.69 0.46

Competitive Comparison of Usana Health Sciences's EV-to-Revenue

For the Packaged Foods subindustry, Usana Health Sciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Usana Health Sciences's EV-to-Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Usana Health Sciences's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Usana Health Sciences's EV-to-Revenue falls into.


;
;

Usana Health Sciences EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Usana Health Sciences's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=412.087/812.978
=0.51

Usana Health Sciences's current Enterprise Value is €412.1 Mil.
Usana Health Sciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €813.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Usana Health Sciences  (STU:USJ) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Usana Health Sciences's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=26.60/42.548
=0.63

Usana Health Sciences's share price for today is €26.60.
Usana Health Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €42.55.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Usana Health Sciences EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Usana Health Sciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Usana Health Sciences Business Description

Traded in Other Exchanges
Address
3838 West Parkway Boulevard, Salt Lake City, UT, USA, 84120
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

Usana Health Sciences Headlines

No Headlines